SOPHiA GENETICS (SOPH) publishes 2025 ESG Impact Summary for investors
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
SOPHiA GENETICS SA filed a Form 6-K noting that it has published its 2025 Environmental, Social and Governance (ESG) Impact Summary as of December 31, 2025. The summary is made available on the company’s website in the Investor Relations section.
Positive
- None.
Negative
- None.
Key Terms
Environmental, Social and Governance Impact Summary, Form 6-K, foreign private issuer, Form 20-F, +1 more
5 terms
Environmental, Social and Governance Impact Summary financial
"today published its Environmental, Social and Governance Impact Summary as per December 31, 2025"
Form 6-K regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Form 20-F regulatory
"whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.
Form 40-F regulatory
"whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F"
A Form 40-F is a standardized annual filing used by certain Canadian companies that trade in U.S. markets to give U.S. regulators and investors the same core financial statements and key disclosures they file in Canada. Think of it as a translated, formally packaged annual report that lets investors in a different marketplace compare a company’s results, governance and risks more easily, which reduces uncertainty and helps investment decisions.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2026.
____________________________________
Commission File Number: 001-40627
SOPHiA GENETICS SA
(Exact name of registrant as specified in its charter)
La Pièce 12
CH-1180 Rolle
Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
| Form 20-F | x | Form 40-F | |||||||||||||||
SIGNATURE
SOPHiA GENETICS SA (the “Company”) today published its Environmental, Social and Governance Impact Summary as per December 31, 2025 (“2025 ESG Impact Summary”). The 2025 ESG Impact Summary is available on www.sophiagenetics.com, in the Investor Relations section.
| SOPHiA GENETICS SA | |||||||||||
| Date: | May 19, 2026 | ||||||||||
| By: | /s/ Daan van Well | ||||||||||
| Name: | Daan van Well | ||||||||||
| Title: | Chief Legal and Regulatory Officer | ||||||||||
EXHIBIT INDEX
| Exhibit No. | Description | ||||
99.1 | 2025 ESG Impact Summary | ||||
FAQ
What did SOPHiA GENETICS (SOPH) announce in its May 2026 Form 6-K?
SOPHiA GENETICS announced that it has published its 2025 Environmental, Social and Governance Impact Summary. The document covers ESG information as of December 31, 2025 and is available through the Investor Relations section of the company’s website.
Where can investors find SOPHiA GENETICS’ 2025 ESG Impact Summary?
The 2025 ESG Impact Summary is available on SOPHiA GENETICS’ website in the Investor Relations section. Investors can access it online as referenced in the company’s May 2026 Form 6-K filing with the U.S. Securities and Exchange Commission.
What period does SOPHiA GENETICS’ 2025 ESG Impact Summary cover?
The 2025 ESG Impact Summary is stated to be “as per December 31, 2025.” This indicates the ESG information in the summary is anchored to that date, providing a snapshot of the company’s environmental, social and governance impact at year-end 2025.
Who signed the SOPHiA GENETICS May 2026 Form 6-K?
The Form 6-K was signed on behalf of SOPHiA GENETICS by Daan van Well. His title in the filing is Chief Legal and Regulatory Officer, indicating responsibility for legal and regulatory matters, including the submission of this report to the SEC.
What exhibit is included with SOPHiA GENETICS’ May 2026 Form 6-K?
The filing includes Exhibit 99.1, described as the 2025 ESG Impact Summary. This exhibit corresponds to the Environmental, Social and Governance Impact Summary document referenced in the main text and made available through SOPHiA GENETICS’ Investor Relations webpage.